Malaria vaccine approved.

'Historic moment': Why the WHO endorsed the first malaria vaccine

First malaria vaccine could be rolled out to billions as World Health Organisation experts give approval | World News

WHO recommends groundbreaking malaria vaccine for children at risk

World's first malaria vaccine approved for use in children in Africa

The Pandemic Has Set Back the Fight Against HIV, TB and Malaria

Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention | NEJM

Vaccine made of live malaria parasites shows early success

A new antimalarial compound can rapidly clear out malaria parasites in infected mice with a single dose while largely avoiding the development of treatment resistance.

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Researchers have shown ‘gene drive’ technology that suppressed populations of a malaria-carrying mosquito in a year-long experiment mimicking natural environments.

Drug researchers discover potent class of molecules that kills malaria parasite

Trial (n=56 people) of a malaria vaccine candidate (PfSPZ-CVac) found the highest doses resulted in a vaccine efficacy of up to 87.5%

mRNA vaccine yields full protection against malaria in mice

mRNA vaccine yields full protection against malaria in mice

First vaccinations have now begun in Mali in a phase III trial of a malaria vaccine developed at the University of Oxford

New malaria vaccine regimen showed 77% vaccine efficacy in malaria-naive volunteers 12 weeks after immunization, which the researchers believe meet the WHO-specified 75% efficacy goal…

The most effective malaria vaccine yet discovered

Malaria is caused by the parasite Plasmodium which is transferred to humans by mosquitos

Altering a mosquito’s gut genes to make them spread antimalarial genes to the next generation of their species shows promise for curbing malaria, according to a study by researchers from Imperial College London

‘Game-changing’ malaria vaccine is 77% effective at stopping infection

Oxford Malaria Vaccine Shows Record High Efficacy of 77% in Children Aged 5-17 Months

A malaria vaccine developed by researchers at the University of Oxford had up to 77% efficacy in a small clinical trial among children in Burkina Faso

A first-of-its-kind study has found that cone snail venom, conotoxin from a species of sea snail, could potentially treat severe malaria, by disrupting the protein-protein interactions of P

First vaccine to fully immunize against malaria builds on pandemic-driven RNA tech

South African scientists discover new chemicals that kill malaria parasite

EJ study: Large-scale anti-malaria campaigns have a globally positive impact

Microneedle patch tests for malaria without needing to draw blood

Malaria parasite hides in human blood by changing how its genes work

Malaria parasites adapt to survive the dry season, research shows

More →